Intestinal Cell News Volume 6.35 | Sep 11 2020

    0
    17







    2020-09-11 | ICN 9.35


    Intestinal Cell News by STEMCELL Technologies
    Vol. 9.35 – 11 September, 2020
    TOP STORY

    ILC1 Drives Intestinal Epithelial and Matrix Remodeling

    Investigators developed gut organoid cocultures with type-1 innate lymphoid cells (ILC1) to dissect the impact of their accumulation in inflamed intestines. They demonstrated that murine and human ILC1 secrete transforming growth factor β1, driving expansion of CD44v6+ epithelial crypts.
    [Nature Materials]

    Abstract

    Immunofluorescence image of adult stem cell-derived intestinal organoids.
    PUBLICATIONSRanked by the impact factor of the journal

    Engineering Transplantable Jejunal Mucosal Grafts Using Patient-Derived Organoids from Children with Intestinal Failure

    Researchers constructed autologous jejunal mucosal grafts using biomaterials from pediatric patients and showed that patient-derived organoids could be expanded efficiently in vitro.
    [Nature Medicine]

    Full ArticlePress Release

    Lighting Up the Fire in Cold Tumors to Improve Cancer Immunotherapy by Blocking the Activity of the Autophagy-Related Protein PIK3C3/VPS34

    The authors revealed that genetically targeting the autophagy-related protein PIK3C3/VPS34 in melanoma and colorectal tumor cells, or treating tumor-bearing mice with selective inhibitors of the PIK3C3/VPS34 kinase activity, reprograms cold immune desert tumors into hot, inflamed immune infiltrated tumors.
    [Autophagy]

    Full Article

    Human Norovirus Exhibits Strain-Specific Sensitivity to Host Interferon Pathways in Human Intestinal Enteroids

    To understand human norovirus biology and the epithelial response to infection, the authors performed transcriptomic analyses, RT-qPCR, CRISPR-Cas9 modification of human intestinal enteroid cultures, and functional studies with two virus strains.
    [Proceedings of the National Academy of Sciences of the United States of America]

    Abstract

    5-Fluorouracil Enhances the Anti-Tumor Activity of the Glutaminase Inhibitor CB-839 against PIK3CA-Mutant Colorectal Cancers

    Investigators report that the glutaminase inhibitor CB-839 preferentially inhibited xenograft growth of PIK3CA-mutant, but not wild-type, colorectal cancer. Moreover, the combination of CB-839 and 5-fluorouracil induces PIK3CA-mutant tumor regression in xenograft models.
    [Cancer Research]

    Abstract

    Androgen Maintains Intestinal Homeostasis by Inhibiting BMP Signaling via Intestinal Stromal Cells

    Scientists report the roles of androgen in proliferation and differentiation of intestinal stem cells via targeting of the androgen receptor on intestinal stromal cells by negatively regulating BMP signaling.
    [Stem Cell Reports]

    Full Article

    VDR–SOX2 Signaling Promotes Colorectal Cancer Stemness and Malignancy in an Acidic Microenvironment

    Researchers revealed that acidosis reduced vitamin D receptor (VDR) expression by downregulating peroxisome proliferator-activated receptor delta expression. Overexpression of VDR effectively suppressed the stemness and oxaliplatin resistance of cells in acidosis.
    [Signal Transduction and Targeted Therapy]

    Full Article

    Upregulation of CPT1A Is Essential for the Tumor-Promoting Effect of Adipocytes in Colon Cancer

    Investigators demonstrated that carnitine palmitoyltransferase I (CPT1A), a key enzyme controlling fatty acid oxidation, was upregulated in colon cancer cells upon exposure to adipocytes or fatty acids.
    [Cell Death & Disease]

    Full Article

    IRF2 Maintains the Stemness of Colonic Stem Cells by Limiting Physiological Stress from Interferon

    Using a dextran sodium sulfate-induced colitis model, researchers explored the role of interferon regulatory factor-2 in maintaining colonic epithelial stem cells.
    [Scientific Reports]

    Full Article

    Download an e-book covering the evolution of organoids, from their development to updated applications and future outlooks.
    REVIEWS

    Tumor Budding in Solid Cancers

    The authors provide an overview of tumor budding in solid cancers, highlighting the molecular and biological aspects of this phenomenon, including its associations with epithelial–mesenchymal transition and features of the tumor microenvironment.
    [Nature Reviews Clinical Oncology]

    Abstract

    INDUSTRY AND POLICY NEWS

    VBL Therapeutics Announces Enrollment of the First Patients in the Phase II Clinical Trial of VB-111 in Metastatic Colorectal Cancer

    VBL Therapeutics announced that the first two patients have been enrolled in the Phase II clinical trial of VB-111 in combination with nivolumab, an immune checkpoint inhibitor, for the treatment of metastatic colorectal cancer.
    [VBL Therapeutics]

    Press Release

    Boehringer Ingelheim Advances Novel Bi-Specific TRAILR2/CDH17 Antibody to Phase I Clinical Trial for Patients Living with Gastrointestinal Cancers

    Boehringer Ingelheim announced the advancement of the bi-specific and tetravalent therapeutic antibody, BI 905711, to its first-in-human clinical trial for patients with advanced gastrointestinal cancers.
    [Boehringer Ingelheim International GmbH]

    Press Release

    FEATURED EVENT

    Cell Biology 2020

    Sep 23
    Virtual

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Associate – The Relationship between Diet, Metabolism, Microbiome, and Colorectal Cancer

    Baylor College of Medicine – Houston, Texas, United States

    Scientist – Gastric Cancer

    The University of Arizona – Tucson, Arizona, United States

    Postdoctoral Fellow – Precision Oncology of Gastrointestinal Cancers

    City of Hope – Monrovia, California, United States

    Postdoctoral Research Associate – Tumor Microenvironment

    USC Lawrence J. Ellison Institute for Transformative Medicine – West Los Angeles, California, United States

    Post Doctoral Fellow – Digestive Diseases

    Emory University – Atlanta, Georgia, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Intestinal Cell News Twitter